REED ELIZABETH E (SVP, GC & Corporate Secretary) sold 26.2% of their position (37.50K shares) of TRAVERE THERAPEUTICS, INC. on the open market
Open‑market sale worth $2.34M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+37.50K
Price / share
$15.46
Trade value
$579.75K
% of position
Common Stock
Shares
−21.93K
Price / share
$62.03
Trade value
$1.36M
% of position
Common Stock
Shares
−13.87K
Price / share
$62.63
Trade value
$868.96K
% of position
Common Stock
Shares
−1.40K
Price / share
$63.69
Trade value
$89.17K
% of position
Common Stock
Shares
−300.00
Price / share
$65.31
Trade value
$19.59K
% of position
Net shares
+0.00
Net value
-$1.76M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/15/2026 | M · Option Exercise | +37.50K | $15.46 | $579.75K | 35.6% | 105.39K | 142.89K |
| Common Stock Direct | 9/15/2026 | S · Sale | −21.93K | $62.03 | $1.36M | 15.3% | 142.89K | 120.96K |
| Common Stock Direct | 9/15/2026 | S · Sale | −13.87K | $62.63 | $868.96K | 11.5% | 120.96K | 107.09K |
| Common Stock Direct | 9/15/2026 | S · Sale | −1.40K | $63.69 | $89.17K | 1.3% | 107.09K | 105.69K |
| Common Stock Direct | 9/15/2026 | S · Sale | −300.00 | $65.31 | $19.59K | 0.3% | 105.69K | 105.39K |
| Total | +0.00 | -$1.76M | ||||||
Employee stock option (right to buy)
Common Stock
37.50K shares
Shares
−37.50K
Strike price
15.46
Held after
0.00
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee stock option (right to buy) Direct | Common Stock37.50K shares | 9/15/2026 | M · Option Exercise | −37.50K | 15.46 | — | 0.00 |